An advisory panel reporting to the U.S. Food and Drug Administration (FDA) is recommending that the diabetes drug Avandia be kept on the market, with major restrictions. This decision comes after a two-day meeting in which 33 health experts heard evidence on whether Avandia increases the risk of patient heart attacks and death. Drugmaker GlaxoSmithKline was faulted by some panel members for falsifying data on major side effects, and in the end 17 of the panel members voted to keep the drug on...
Read moreIn my last blog posted here on OsteoporosisConnection.com, I discussed the need for vitamin D testing for those who want to have their... Read more »
Adopting a gluten-free lifestyle is necessary for individuals with Celiac Disease (CD) or Gluten Sensitivity (GS) in order to become and... Read more »
I just received a news release indicating that if you live in the state of New York and are on Medicaid, access to your medications may be... Read more »
The U.S. Food and Drug Administration (FDA) is restricting the use of Avandia to patients who cannot control their diabetes on other medications. The... Read more »
An expert panel that advises the U.S. Food and Drug Administration (FDA) has recommended that the new osteoporosis drug Fablyn's use should be... Read more »
A panel that advises the U.S. Food and Drug Administration will meet this week to debate further restrictions on tanning beds, which some experts say... Read more »
The U.S. Food and Drug Administration (FDA) has outlawed free samples of cigarettes and banned the use of tobacco brand names on freebies handed out... Read more »
The Canadian counterpart to the U.S. Food and Drug Administration has rejected the advice of its own experts to place ibuprofen behind the counter at... Read more »